Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 2, 2016
Patent Application Number
14125554
Date Filed
January 25, 2013
Patent Citations Received
Patent Primary Examiner
Patent abstract
Hormone replacement therapies are provided comprising solubilized progesterone alone and optionally with an estrogen, cyclic/sequential and continuous-combined dosing, and administered via transdermal HRT delivery systems.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
